|
|
|
|
| Symbol(s): |
AMED |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
Amedisys has a current Overall Rating of B (Positive). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Amedisys has a current Overall Rating of B (Positive). Power Rating (84) is very high; appreciation potential (53) is neutral. Relative to the S&P 500 Composite, Amedisys Inc has moderate Growth characteristics -- its appeal is likely to be to Capital Gain-oriented investors. AMED is of average investment quality. Amedisys' current technical position is very strong. Amedisys' Power Rating is 84. Earnings estimate behavior for AMED has been slightly favorable recently. Amedisys' Home...
| | |
|
|
